Hoba Therapeutics
PrivateLast Round
Series A
Dec 11, 2023
Total Funding Raised
$30.95M
Company Overview
Hoba Therapeutics is a biotechnology company that develops novel therapeutic proteins for the treatment of chronic neuropathic pain and sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hoba Therapeutics Comparables
Compare Hoba Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmNovo AB | 83% | |
| Algiax Pharmaceuticals | 78% | |
| Latigo Biotherapeutics | 78% | |
Hoba Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 11, 2023 | ||||
| Grant | Jun 16, 2021 | ||||
| Grant | Sep 20, 2018 | ||||
| Seed | Nov 1, 2016 |
Key People
Founding team and executive leadership
Hoba Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Medical Incubator Japan | Series A |
| Indaco Venture Partners SGR | Series A |
| Eir Ventures | Series A |
| Novo Holdings | Series A |
| The Export and Investment Fund of Denmark | Series A |
| Borean Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors grew 371% MoM, from 255 to 1.2K.
- Oct 29, 2024
Monthly visitors increased 114% MoM, reaching 1.3K.
Hoba Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hoba Therapeutics's valuation, stock price, and market status.